
Functional Genetics and Psychiatric Disorders
An Exploration of Functional Genetic Variants in Candidate Genes for Psychiatric Disorders
LAP Lambert Academic Publishing
Published on 21. June 2011
Book
Paperback/Softback
96 pages
978-3-8443-8416-1 (ISBN)
Description
Drug addiction is a chronic disorder characterized by compulsive drug seeking and taking despite serious negative consequences. Association studies have identified a number of candidate genes harboring variants associated with susceptibility to addiction, but the causative variants frequently remain unknown. A solution to the challenge of identifying causative variants is the thorough characterization of functional genetic polymorphisms and their effects on regulation of candidate genes. I focused on candidate genes for drug addiction (ARRB2, DRD2, and DRD3) and made some novel and significant findings: The effects of two intronic SNPs in the human dopamine receptor D2 (DRD2) gene, previously shown to alter DRD2 alternative splicing, were confirmed in human brain autopsy tissues obtained from a population of cocaine abusers and controls. The same SNPs were significantly associated with cocaine abuse. The results of this study contribute to our understanding of the functional genetic variation in important candidate genes and have the potential to improve the prevention and treatment of drug addiction and other psychiatric disorders.
More details
Language
English
Place of publication
Germany
Product notice
Paperback (trade)
Unsewn / adhesive bound
Dimensions
Height: 220 mm
Width: 150 mm
Thickness: 6 mm
Weight
161 gr
ISBN-13
978-3-8443-8416-1 (9783844384161)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
Robert Moyer ha conseguito il dottorato di ricerca in Farmacologia molecolare, Farmacogenomica e Terapeutica presso la Ohio State University nel 2010. Il Dr. Wolfgang Sadee รจ Felts Mercer Professor di Medicina e Farmacologia e Presidente del Dipartimento di Farmacologia della Ohio State University.